Healthcare >> CEO Interviews >> June 27, 2005

Ginger Graham – Amylin Pharmaceuticals Inc (amln)

TWST: Would you start with an overview of Amylin?

Ms. Graham: Amylin is in the wonderful position of just having gained

approval from the FDA for two first-in-class, brand-new